Filing Flows › Macrogenics (MGNX) › How it makes money
How Macrogenics (MGNX) makes money
Macrogenics (MGNX) made $32.8M of revenue in the second quarter 2026 (Q2 2026), +379% from a year earlier. Collaborative and other agreements brought in $25.5M (78%); Royalty revenue brought in $7.3M (22%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Collaborative and other agreements | $25.5M | 77.6% | 45× | +359% |
| Royalty revenue | $7.3M | 22.4% | +19% | +465% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $32.8M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $32.8M | +378% |
| Q1 2026 | $20.8M | +58% |
| Q4 2025 | $41.2M | +113% |
| Q3 2025 | $72.8M | -34% |
| Q2 2025 | $22.2M | +106% |
| Q1 2025 | $13.2M | +45% |
| Q4 2024 | $19.4M | +80% |
From Macrogenics' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Macrogenics make money?
Macrogenics (MGNX) made $32.8M of revenue in the second quarter 2026 (Q2 2026), +379% from a year earlier. Collaborative and other agreements brought in $25.5M (78%); Royalty revenue brought in $7.3M (22%).
What is Macrogenics' biggest business?
Collaborative and other agreements: $25.5M in the second quarter 2026, 78% of revenue, +359% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.